PT Suparma Tbk (SPMA) Stock Statistics & Valuation Metrics
Total Valuation
PT Suparma Tbk has a market cap or net worth of IDR 788.90B. The enterprise value is IDR 1.80T.
- Market Cap
- IDR 788.90B
- Enterprise Value
- IDR 1.80T
Share Statistics
PT Suparma Tbk has 5,330,410,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 5,330,410,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
PT Suparma Tbk’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 4.44%.
- Return on Equity (ROE)
- 0.04
- Return on Assets (ROA)
- 0.03
- Return on Invested Capital (ROIC)
- 4.44%
- Return on Capital Employed (ROCE)
- 0.07
- Revenue Per Employee
- 3.24B
- Profits Per Employee
- 125.42M
- Employee Count
- 847
- Asset Turnover
- 0.75
- Inventory Turnover
- 2.11
Valuation Ratios
The current PE Ratio of PT Suparma Tbk is 6.10. PT Suparma Tbk’s PEG ratio is -0.22.
- PE Ratio
- 6.10
- PS Ratio
- 0.29
- PB Ratio
- 0.17
- Price to FCF
- 1.14
- Price to Operating Cash Flow
- 0.55
- PEG Ratio
- -0.22
Income Statement
In the last 12 months, PT Suparma Tbk had revenue of 2.74T and earned 106.23B in profits. Earnings per share was 25.91.
- Revenue
- 2.74T
- Gross Profit
- 425.79B
- Operating Income
- 197.90B
- Pretax Income
- 136.74B
- Net Income
- 106.23B
- EBITDA
- 323.65B
- Earnings Per Share (EPS)
- 25.91
Cash Flow
In the last 12 months, operating cash flow was 792.31B and capital expenditures -84.64B, giving a free cash flow of 707.67B billion.
- Operating Cash Flow
- 792.31B
- Free Cash Flow
- 707.67B
- Free Cash Flow per Share
- 246.66
Dividends & Yields
PT Suparma Tbk pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 87.92%
- Earnings Yield
- 20.79%
Stock Price Statistics
- Beta
- 0.56
- 52-Week Price Change
- -32.40%
- 50-Day Moving Average
- 161.46
- 200-Day Moving Average
- 164.01
- Relative Strength Index (RSI)
- 41.75
- Average Volume (3m)
- 387.48K
Important Dates
PT Suparma Tbk upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 30, 2026
- Next Earnings Date
- Apr 01, 2027
- Ex-Dividend Date
- ―
Financial Position
PT Suparma Tbk as a current ratio of 2.00, with Debt / Equity ratio of 28.62%
- Current Ratio
- 2.00
- Quick Ratio
- 0.59
- Debt to Market Cap
- 0.85
- Net Debt to EBITDA
- 1.59
- Interest Coverage Ratio
- 4.39
Taxes
In the past 12 months, PT Suparma Tbk has paid 30.51B in taxes.
- Income Tax
- 30.51B
- Effective Tax Rate
- 0.22
Enterprise Valuation
PT Suparma Tbk EV to EBITDA ratio is 4.69, with an EV/FCF ratio of 2.24.
- EV to Sales
- 0.56
- EV to EBITDA
- 4.69
- EV to Free Cash Flow
- 2.24
- EV to Operating Cash Flow
- 2.00
Balance Sheet
PT Suparma Tbk has IDR 127.08B in cash and marketable securities with IDR 907.54B in debt, giving a net cash position of -IDR 780.46B billion.
- Cash & Marketable Securities
- IDR 127.08B
- Total Debt
- IDR 907.54B
- Net Cash
- -IDR 780.46B
- Net Cash Per Share
- -IDR 146.42
- Tangible Book Value Per Share
- IDR 879.77
Margins
Gross margin is 16.68%, with operating margin of 8.40%, and net profit margin of 3.20%.
- Gross Margin
- 16.68%
- Operating Margin
- 8.40%
- Pretax Margin
- 4.18%
- Net Profit Margin
- 3.20%
- EBITDA Margin
- 12.00%
- EBIT Margin
- 7.51%
Analyst Forecast
The average price target for PT Suparma Tbk is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 6.97%
- EPS Growth Forecast
- 73.26%
